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OBJECTIVES: Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects reproductive-age
women. The mechanisms underlying the endocrine heterogeneity and neuroendocrinology of polycystic ovary
syndrome are still unclear. In this study, we investigated the expression of the kisspeptin system and
gonadotropin-releasing hormone pulse regulators in the hypothalamus as well as factors related to luteinizing
hormone secretion in the pituitary of polycystic ovary syndrome rat models induced by testosterone or estradiol.
METHODS: A single injection of testosterone propionate (1.25 mg) (n=10) or estradiol benzoate (0.5 mg) (n=10)
was administered to female rats at 2 days of age to induce experimental polycystic ovary syndrome. Controls
were injected with a vehicle (n=10). Animals were euthanized at 90-94 days of age, and the hypothalamus and
pituitary gland were used for gene expression analysis.
RESULTS: Rats exposed to testosterone exhibited increased transcriptional expression of the androgen receptor
and estrogen receptor-b and reduced expression of kisspeptin in the hypothalamus. However, rats exposed to
estradiol did not show any significant changes in hormone levels relative to controls but exhibited
hypothalamic downregulation of kisspeptin, tachykinin 3 and estrogen receptor-a genes and upregulation of
the gene that encodes the kisspeptin receptor.
CONCLUSIONS: Testosterone- and estradiol-exposed rats with different endocrine phenotypes showed dif-
ferential transcriptional expression of members of the kisspeptin system and sex steroid receptors in the
hypothalamus. These differences might account for the different endocrine phenotypes found in testosterone-
and estradiol-induced polycystic ovary syndrome rats.
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’ INTRODUCTION
Polycystic ovary syndrome (PCOS) is a highly prevalent
heterogeneous condition mainly characterized by hyperan-
drogenism, chronic anovulation and polycystic ovaries (1).
Another abnormality that is common in women with PCOS
is aberrant gonadotropin-releasing hormone (GnRH) secre-
tion, which favors higher production of luteinizing hormone
(LH) and an increase in androgen production by the ovaries
(2). However, the precise mechanisms underlying LH hyper-
secretion in PCOS are not well known.
The kisspeptin system, which includes kisspeptin, dynor-
phin A and neurokinin B/tachykinin 3, is essential for
GnRH/LH pulse control, and it is believed that impairments
in this system might contribute to endocrine dysfunction in
PCOS (3). Furthermore, evidence suggests that neuroendocrine
dysfunction in insulin signaling alters GnRH/LH secretion and
impair reproductive cyclicity (4).DOI: 10.6061/clinics/2017(08)09
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RAPID COMMUNICATION
Exposure to either estrogen or androgens in neonatal life
can induce chronic anovulation and polycystic ovaries
resembling human PCOS during rat adulthood (5). However,
different exposures may result in various endocrine pheno-
types (5). For instance, animals exposed to androgens dur-
ing the neonatal period present increased levels of LH and
testosterone. This phenotype is not observed in the estrogen
model (6). The aim of this study was to investigate tran-
scriptional changes in the kisspeptin system and GnRH pulse
regulators in the hypothalamus as well as factors related to
LH secretion in the pituitary in PCOS rat models induced by
testosterone or estradiol.
’ MATERIALS AND METHODS
Animals
The experimental procedures were described previously
(6). In brief, thirty female Wistar rats at 2 days of age were
allocated into the following groups for the induction of
experimental PCOS: subcutaneous injection of 1.25 mg of
testosterone (TG; n=10) (7) or 0.5 mg of estradiol (EG; n=10)
(8). Control animals received a single injection of olive oil
(vehicle) (CG; n=10). At 90-94 days of age, under anesthesia,
blood was obtained from the abdominal aortic artery, ani-
mals were decapitated, and the hypothalamus and pitui-
tary gland were removed and stored in RNAlater solution
(Ambion; Thermo Fisher Scientific, USA) for 24 h and frozen
until use. The measurement of serum levels of LH, FSH and
testosterone is described in our previous study (6). This
study was approved by the Institutional Ethics Committee of
Faculdade de Medicina da Universidade de São Paulo under
protocol number 151/10.
Quantitative real-time polymerase chain reaction
(qRT-PCR)
RNA extraction, cDNA synthesis and qRT-PCR conditions
were performed as described elsewhere (9). Taqmans assays
manufactured by Life Technologies were selected to analyze
the gene expression of Gnrh, Gnrhr, Kiss1, Kiss1r, Tac3, Tacr3,
Esr1, Esr2, Ar, Cyp19a1, Pdyn and Oprk1 in the hypothalamus
and Gnrhr, Kiss1, Kiss1r, Insr and Ar in the pituitary (Table 1).
The data were analyzed using Sequence Detection Software
(version 2.0.6), and Ct values were transformed to quantities
using the comparative Ct method (DDCt).
Statistical analysis
Statistical analyses were performed with GraphPad Prism
(version 6.05; GraphPad Software, USA). ANOVA followed
by the Bonferroni post hoc test was performed to analyze data
with a normal distribution. For skewed data, the Kruskal-
Wallis test followed by Dunn’s post hoc test was performed.
A value of po0.05 was considered to indicate statistical sig-
nificance. F-ratios (F) are described for significant differences.
The degrees of freedom was equal to 29 for all analyses.
’ RESULTS
Treated rats had closed vaginas, and all rats in the CG had
normal estrous cycles. In the hypothalamus, kisspeptin
(Kiss1), neurokinin B (Tac3), and estrogen receptor (ER)-a
(Esr1) were downregulated in the EG relative to the CG
(p=0.0001, F=35.92; p=0.01, F=5.193; and p=0.0015, F=8.342,
respectively). The expression levels of Kiss1 and GnRH
receptor (Gnrhr) were lower in the EG than in the TG (Kiss1:
p=0.01, F=35.92; Gnrhr: p=0.01, F=6.748), and the expression
of the gene encoding the KISS1 receptor (Kiss1r) was higher
in the EG than in the CG (p=0.007, F=5.142). Kiss1 was also
expressed at a lower level in the TG than in the CG (p=0.001,
F=35.92). TG rats exhibited upregulation of the androgen
receptor (Ar) and ER-b (Esr2) genes compared to CG animals
(p=0.04, F=3.522; and P=0.02, F=4.497, respectively). The
expression of Gnrh, Oprk1, Pdyn, Tacr3 and Cyp19a1 did
not differ significantly among the groups (Figure 1A). No
significant difference was observed in pituitary gene expres-
sion (Figure 1B), and Kiss1 and Kiss1r mRNA levels were
undetectable.
’ DISCUSSION
Our group showed in a previous study that testosterone or
estradiol exposure in neonatal life leads to different PCOS-
like phenotypes in adult female rats. Testosterone-induced
PCOS rat models exhibit increased LH and testosterone
Table 1 - Description of the probes and primers used in the study.
Gene symbol Gene name TaqMan ID RefSeq
Reference genes
Actb Actin, Beta 4352340E NM_031144.3
Gapdh Glyceraldehyde-3-Phosphate Dehydrogenase 4352338E NM_017008.4
Ppia Peptidylprolyl Isomerase A (Cyclophilin A) Rn00690933_m1 NM_017101.1
Target genes
Gnrh1 Gonadotropin-Releasing Hormone 1 Rn00562754_m1 NM_012767.2
Gnrhr Gonadotropin-Releasing Hormone Receptor Rn00578981_m1 NM_031038.3
Kiss1 Kisspeptin Rn00710914_m1 NM_181692.1
Kiss1r KISS1 Receptor Rn00576940_m1 NM_023992.2 and NM_001301151.1
Tac3 Tachykinin 3 Rn00569758_m1 NM_019162.2
Tacr3 Tachykinin Receptor 3 Rn00566955_m1 NM_017053.1
Pdyn Prodynorphin Rn00571351_m1 NM_019374.3
Oprk1 Opioid Receptor, Kappa 1 Rn01448892_m1 NM_017167.2
Esr1 Estrogen Receptor 1 (ER Alpha) Rn01640372_m1 NM_012689.1
Esr2 Estrogen Receptor 2 (ER Beta) Rn00562610_m1 NM_012754.1
Ar Androgen Receptor Rn00560747_m1 NM_012502.1
Insr Insulin Receptor Rn00690703_m1 NM_017071.2
Cyp19a1 Cytochrome P450, Family 19, Subfamily A, Polypeptide 1 Rn00567222_m1 NM_017085.2
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levels, anovulation, and polycystic ovaries, while estradiol-
induced PCOS rat models exhibit anovulation and polycystic
ovaries but no alterations in the serum levels of gonado-
tropins or testosterone (6). In the current study, we aimed to
further understand the heterogeneity of PCOS endocrine
phenotypes by studying the hypothalamic neuroendocrine
transcriptional profile of the kisspeptin system and GnRH
pulse regulators as well as factors related to LH secretion in
the pituitary of these two PCOS rat models.
It has been hypothesized that androgenized rat models
have increased GnRH expression (10), and this event, in part,
seems to be mediated by the interaction of androgens with
androgen receptors (ARs) in the hypothalamus (11). Feng et
al. (10) have shown that the AR is co-expressed in GnRH-
neurons of adult female rats. In rats exposed to androgens in
this study, an upregulation of Ar occurred in the hypotha-
lamus. In vitro, AR activation has been shown to increase
GnRH-neuron firing activity and GnRH secretion (12, 13).
Kisspeptin is an important factor involved in the stimula-
tion of GnRH/LH secretion as well as the GnRH/LH surge
that induces ovulation (3). Androgen and estrogen exposure
downregulate kisspeptin gene expression, with this effect
being more pronounced in estrogen-exposed rats. The down-
regulation of kisspeptin might be related to anovulation,
because those animals seem to be unable to generate the
GnRH/LH surge (6). In contrast, the KISS1 receptor gene
was upregulated in rats exposed to estrogen, which is
possibly a compensatory mechanism for low levels of
kisspeptin.
Despite downregulation of the kisspeptin gene, androgen-
exposed rats presented increased levels of LH. However,
GnRH pulsatility, which stimulates gonadotropin secretion
in a GnRH pulse-dependent manner, as well as LH secretion,
is modulated by many factors (14). Other factors might be
involved in LH hypersecretion in androgen-exposed rats.
Another factor that might contribute to anovulation in
estrogen-exposed rats is the lower level of ER-a mRNA
because female rats treated with an ER-a antagonist could
not achieve a GnRH/LH surge, even with induction of
the LH surge by intracerebroventricular administration of
kisspeptin. However, the central administration of an ER-b
antagonist did not impair the GnRH/LH surge in female rats
(15). Mice with ER-b knockdown, but not those with ER-a
knockdown, can generate positive estrogen-mediated feed-
back for the LH surge, and the action of a specific ligand of
ER-a induces the LH surge (16). ER-a is expressed at a higher
level in kisspeptin neurons than in GnRH neurons, while
ER-b is the main estrogen receptor in GnRH neurons (17),
which suggests that estrogen-exposed rats cannot achieve
positive kisspeptin neuron-mediated estrogen feedback for
GnRH/LH secretion. Androgen-induced PCOS rats exhib-
ited upregulation of the ER-b gene. The role of ER-b in
Figure 1 - Transcriptional expression in the hypothalamus and pituitary. The data are shown as the means± SEM. ANOVA followed by
Bonferroni’s test was performed for data with a normal distribution, and the Kruskal-Wallis test followed by Dunn’s post hoc test
was performed for skewed data. (A) mRNA expression in the hypothalamus. (B) mRNA expression in the pituitary. * - vs the CG
(po0.05), # - EG vs TG (po0.05).
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reproduction is not completely known, but this receptor also
interacts with an androgen metabolite called 3b-diol (18).
However, the role of this metabolite in the GnRH or kiss-
peptin system is still unknown.
Neurokinin B is considered an important factor in the
modulation of GnRH secretion because loss-of-function
mutations in the genes encoding both neurokinin B and its
receptor induce hypogonadotropic hypogonadism (19). Fur-
thermore, the central administration of a neurokinin B
receptor agonist increases LH secretion in female rats (20).
Downregulation of the neurokinin B gene (Tac3) may be
related to the state of anovulation in estradiol-exposed rats
and the lower levels of LH in the estradiol-exposed rats
relative to the androgen-exposed rats. Additionally, testos-
terone- and estradiol-induced PCOS rat models differ regard-
ing GnRH receptor mRNA expression in the hypothalamus,
which might contribute to the neuroendocrine differences in
those rat models.
To the best of our knowledge, this is the first study to
compare the transcriptional expression in neuroendocrine
organs in PCOS rat models with different endocrine pheno-
types. However, this is a preliminary study, and one limi-
tation is the absence of protein expression analysis.
In summary, we found that testosterone- and estradiol-
induced PCOS rats with different endocrine phenotypes
exhibit differential transcriptional expression of members
of the kisspeptin system and sex steroids in the hypothala-
mus. It is possible that different insults during development
activate various neuronal circuitries, which might be related
to the heterogeneity of PCOS. The hypothesized effects of
altered hypothalamic transcriptional expression on endo-
crine phenotypes are summarized in Figure 2. These diffe-
rences seem to be caused by various mechanisms and might
account for the different neuroendocrine and endocrine
phenotypes found in androgen- and estrogen-induced PCOS
rats and women with PCOS.
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Figure 2 - Differential transcriptional expression in the hypothalamus and hypothesized effects on the endocrine phenotypes of
estradiol- or testosterone-induced PCOS rat models. The diagram shows genes with altered expression in the hypothalamus of
estradiol- or testosterone-induced PCOS rat models; these two models only share the downregulation of the kisspeptin gene (Kiss1).
Downregulation of the kisspeptin gene might contribute to anovulation in both testosterone- and estradiol-induced PCOS rat models
because kisspeptin is essential for the gonadotropin-releasing (GnRH)/luteinizing hormone (LH) surge that precedes ovulation. The
testosterone-induced PCOS rat model seems to have increased androgen-mediated stimulation of GnRH neurons, which might increase
GnRH pulsatility and increase LH secretion by the pituitary. Increased LH secretion per se stimulates the ovaries to increase testosterone
production. In the estradiol-induced PCOS rat model, downregulation of the estrogen receptor-a (ER-a) and tachykinin 3 genes seems
to impair the GnRH/LH surge and ovulation. k, decreased; m, increased.
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